导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.97% | 523/1050 |
| 近一周 | -1.33% | 181/1104 |
| 近一月 | 1.21% | 52/1102 |
| 近一季 | 0.01% | 256/1092 |
| 近半年 | -5.50% | 632/1070 |
| 近一年 | -2.00% | 619/1018 |
| 近两年 | 23.53% | 739/926 |
| 近三年 | 12.49% | 574/834 |
| 成立以来 | 54.88% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.46% 170/1070 |
-13.94% 999/1101 |
- - |
- - |
| 2025 | 6.81% 860/1065 |
-0.41% 821/1014 |
8.29% 152/1038 |
0.25% 1000/1050 |
-1.21% 511/1065 |
| 2024 | 14.58% 184/1011 |
9.40% 33/960 |
6.71% 59/983 |
-1.45% 965/991 |
-0.40% 344/1011 |
| 2023 | -5.22% 207/952 |
1.18% 561/880 |
3.37% 64/895 |
-1.48% 134/915 |
-8.01% 758/952 |
| 2022 | -20.91% 362/867 |
-16.39% 322/773 |
-3.48% 744/806 |
-7.46% 118/845 |
5.91% 170/867 |
| 2021 | 1.98% 336/740 |
1.41% 100/580 |
6.67% 433/659 |
-9.80% 500/704 |
4.52% 242/740 |
| 2020 | 34.75% 330/554 |
-12.86% 396/419 |
13.35% 372/466 |
22.65% 34/517 |
11.23% 324/554 |
| 2019 | 28.76% 297/410 |
18.94% 942/1149 |
1.63% 193/1231 |
0.77% 316/390 |
5.71% 325/410 |
| 2018 | -18.63% 54/349 |
- - |
- - |
- - |
-14.46% 854/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 平安股息精选沪港深A VS. 东吴新产业精选股票A(580008) |